Watch Ticker

eFFECTOR Therapeutics, Inc. Common Stock

Go to eFFECTOR Therapeutics, Inc. Common Stock Website

$2.20

(%)

Live

Previous Close

$2.2

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$10.3 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs)....

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

eFFECTOR Therapeutics, Inc. - eFFECTOR Therapeutics to Participate in Upcoming Investor Conference

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (“STRIs”) for the treatment of cancer, today announced that the Company will present at the Stifel Virtual Oncology Forum on Tuesday, April 16th at 11:30 am ET.

Related tickers: EFTR.

Read Full Article

Zacks Equity Research - eFFECTOR Therapeutics (EFTR) Plunges 82% as NSCLC Study Fails

eFFECTOR Therapeutics (EFTR) plunges on disappointing top-line results from the primary analysis of its mid-stage NSCLC study of tomivosertib, following the abandonment of the developmental program.

Related tickers: MRK, ADMA, FGEN, EFTR.

Read Full Article

Trending Tickers

LASE

XNAS

$2.04

(%)

PACW

XNAS

$7.54

(%)

SMFL

XNAS

$3.58

(%)

XNYS

$69.47

(%)

MLGO

XNAS

$2.42

(%)